Tags

Type your tag names separated by a space and hit enter

Chemodivergent metathesis of dienynes catalyzed by ruthenium-indenylidene complexes: an experimental and computational study.
Chemistry. 2009 Oct 05; 15(39):10244-54.C

Abstract

A study on the enyne metathesis reaction leading to the formation cyclic compounds using ruthenium-indenylidene complexes is presented. Several 1,11-dien-6-ynes have been subjected to ruthenium metathesis cyclization by using ruthenium-indenylidene complexes bearing various phosphine and N-heterocyclic carbene (NHC) ligands. Interestingly, for some substrates chemodivergent metathesis occurs and is a function of the catalyst employed. This led us to investigate the competing "ene-then-yne" or "yne-then-ene" reaction pathways apparently at play in these systems using both experimental observations and DFT calculations. Experimental and computational studies were found in good agreement and permit to conclude that for phosphine-containing catalysts, the "ene-then-yne" pathway is exclusively adopted. On the other hand, for catalysts bearing NHC ligands, both pathways are possible.

Authors+Show Affiliations

School of Chemistry, University of St-Andrews, North Haugh, St Andrews, KY16 9ST, UK.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

19711384

Citation

Clavier, Hervé, et al. "Chemodivergent Metathesis of Dienynes Catalyzed By Ruthenium-indenylidene Complexes: an Experimental and Computational Study." Chemistry (Weinheim an Der Bergstrasse, Germany), vol. 15, no. 39, 2009, pp. 10244-54.
Clavier H, Correa A, Escudero-Adán EC, et al. Chemodivergent metathesis of dienynes catalyzed by ruthenium-indenylidene complexes: an experimental and computational study. Chemistry. 2009;15(39):10244-54.
Clavier, H., Correa, A., Escudero-Adán, E. C., Benet-Buchholz, J., Cavallo, L., & Nolan, S. P. (2009). Chemodivergent metathesis of dienynes catalyzed by ruthenium-indenylidene complexes: an experimental and computational study. Chemistry (Weinheim an Der Bergstrasse, Germany), 15(39), 10244-54. https://doi.org/10.1002/chem.200900976
Clavier H, et al. Chemodivergent Metathesis of Dienynes Catalyzed By Ruthenium-indenylidene Complexes: an Experimental and Computational Study. Chemistry. 2009 Oct 5;15(39):10244-54. PubMed PMID: 19711384.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Chemodivergent metathesis of dienynes catalyzed by ruthenium-indenylidene complexes: an experimental and computational study. AU - Clavier,Hervé, AU - Correa,Andrea, AU - Escudero-Adán,Eduardo C, AU - Benet-Buchholz,Jordi, AU - Cavallo,Luigi, AU - Nolan,Steven P, PY - 2009/8/28/entrez PY - 2009/8/28/pubmed PY - 2010/2/18/medline SP - 10244 EP - 54 JF - Chemistry (Weinheim an der Bergstrasse, Germany) JO - Chemistry VL - 15 IS - 39 N2 - A study on the enyne metathesis reaction leading to the formation cyclic compounds using ruthenium-indenylidene complexes is presented. Several 1,11-dien-6-ynes have been subjected to ruthenium metathesis cyclization by using ruthenium-indenylidene complexes bearing various phosphine and N-heterocyclic carbene (NHC) ligands. Interestingly, for some substrates chemodivergent metathesis occurs and is a function of the catalyst employed. This led us to investigate the competing "ene-then-yne" or "yne-then-ene" reaction pathways apparently at play in these systems using both experimental observations and DFT calculations. Experimental and computational studies were found in good agreement and permit to conclude that for phosphine-containing catalysts, the "ene-then-yne" pathway is exclusively adopted. On the other hand, for catalysts bearing NHC ligands, both pathways are possible. SN - 1521-3765 UR - https://www.unboundmedicine.com/medline/citation/19711384/Chemodivergent_metathesis_of_dienynes_catalyzed_by_ruthenium_indenylidene_complexes:_an_experimental_and_computational_study_ L2 - https://doi.org/10.1002/chem.200900976 DB - PRIME DP - Unbound Medicine ER -